Clinics near me
AU/NZ

Europe

Americas

Asia Pacific

Eurasia & Middle East

Leading Non-Invasive Facial Balancing Solution for Aesthetic Clinics

Enquire Now

By BTL: as seen in

Vogue-logo
Cosmopolitan-Emblem
marie
mamamia logo
Untitled (250 x 90 px) (1)
urban
womens-fitness-magazine-logo

Introducing EMFACE

EMFACE is the market-first device that simultaneously stimulates facial muscles and remodels skin using a patented combination of HIFES and Synchronized RF technologies.

Designed for clinics looking to deliver natural-looking, non-invasive facial rejuvenation results, EMFACE targets the full facial structure, from muscle to skin.

Emface_PIC_Infographic-Without-Informations-534px_EN100_1706261123_original

Volume and Lift Without Injectables or Downtime

EMFACE firms the facial framework and lifts the skin using our 2-in-1 technology:

  • Synchronized Radiofrequency (RF) to remodel skin and stimulate collagen and elastin
  • HIFES® (High-Intensity Facial Electrical Stimulation) to selectively tone and elevate facial muscles

This dual-technology approach allows providers to address facial volume loss, sagging, and visible signs of aging without injectables or surgery.

Precise Facial Elevation

EMFACE delivers measurable lifting and contouring by targeting the muscles and skin that support facial structure.

Clinical results show visible improvements across multiple facial areas.

  • Up to 37% reduction in forehead wrinkles
  • Average eyebrow lift of 3.3 mm
  • 1.4 ml reduction in under eye bag volume
  • 36% reduction in submental fullness

Seeing is believing

Click on the desired area for EMFACE results.

Eyes
Submentum
Full Face
Forehead
Cheeks
Jawline
BEFORE
AFTER
Emface_PIC_Ba-card-171-female-eyes-before_EN100_1737622779_original
Emface_PIC_Ba-card-171-female-eyes-after_EN100_1737622778_original
Emface_PIC_Ba-card-160-female-eyes-after_EN100_1737622779_original
Emface_PIC_Ba-card-160-female-eyes-before_EN100_1737622780_original
Emface_PIC_Ba-card-164-female-eyes-after_EN100_1737622781_original
Emface_PIC_Ba-card-164-female-eyes-before_EN100_1737622781_original
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
Emface_PIC_Ba-110-card-female-before-submentum_ENUS100_1706022454_original
Emface_PIC_Ba-110-card-female-after-submentum_ENUS100_1706022453_original
Emface_PIC_Ba-111-card-female-before-submentum_ENUS100_1706022455_original
Emface_PIC_Ba-111-card-female-after-submentum_ENUS100_1706022454_original
Emface_PIC_Ba-115-card-male-before-submentum_ENUS100_1706022456_original
Emface_PIC_Ba-115-card-male-after-submentum_ENUS100_1706022455_original
Emface_PIC_Ba-117-card-female-before-submentum_ENUS100_1706022458_original
Emface_PIC_Ba-117-card-female-after-submentum_ENUS100_1706022457_original
Emface_PIC_Ba-118-card-female-before-submentum_ENUS100_1706022459_original
Emface_PIC_Ba-118-card-female-after-submentum_ENUS100_1706022459_original
Emface_PIC_Ba-121-card-female-before-submentum_ENUS100_1706022461_original
Emface_PIC_Ba-121-card-female-after-submentum_ENUS100_1706022460_original
AFTER 4ᵀᴴ TREATMENT, COURTESY OF: Chris W. Robb, M.D.
AFTER 4ᵀᴴ TREATMENT, COURTESY OF: Carolyn Jacob, M.D
AFTER 4ᵀᴴ TREATMENT, COURTESY OF: Barry Dibernardo, M.D.
AFTER 4ᵀᴴ TREATMENT, COURTESY OF: Lesley Clark-Loeser, M.D.
AFTER 4ᵀᴴ TREATMENT, COURTESY OF: Carolyn Jacob, M.D.
1 MONTH AFTER 4ᵀᴴ TREATMENT, COURTESY OF: Chris W. Robb, M.D.
Emface_PIC_057-Before-face-female-Joel-L-Cohen-MD_101_412x296px_1672383853_original
Emface_PIC_057-After-face-female-Joel-L-Cohen-MD4TX_101_412x296px_1672383887_original
Emface_PIC_030-Before-face-female-Yael-Halaas-MD_101_412x296px_1672383929_original
Emface_PIC_030-After-face-female-Yael-Halaas-MD-4TX_101_412x296px_1672383944_original
Emface_PIC_032-Before-face-female-Yael-Halaas-MD_101_412x296px_1672383964_original
Emface_PIC_032-After-face-female-Yael-Halaas-MD-4TX_101_412x296px_1672383982_original
Emface_PIC_052-Before-face-female-Richar-Gentile-MD_412x296px_1664798061_original_v2_1748259996_original
Emface_PIC_052-After-face-female-Richar-Gentile-MD-1M-AL_412x296px_1664798060_original_v2_1748260023_original
Emface_PIC_053-Before-face-male-Charles-Boyd-MD_101_412x296px_1672384043_original
Emface_PIC_053-After-face-male-Charles-Boyd-MD-4TX_101_412x296px_1672384061_original
AFTER 4ᵀᴴ TREATMENT
3 MONTHS AFTER 4ᵀᴴ TREATMENT
3 MONTHS AFTER 4ᵀᴴ TREATMENT
3 MONTHS AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
Emface_PIC_021-Before-forehead-female-BTL-Aesthetics_412x296px_1663830082_original
Emface_PIC_021-After-forehead-female-BTL-Aesthetics-3M_412x296px_1663830082_original
Emface_PIC_053-Before-face-male-Charles-Boyd-MD_101_412x296px_1_1672384315_original
Emface_PIC_053-After-face-male-Charles-Boyd-MD-4TX_101_412x296px_1_1672384329_original
3 MONTHS AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
Emface_PIC_047-After-face-male-Charles-Boyd-MD-3M-4TX_412x296px_1663831022_original
Emface_PIC_047-Before-face-male-Charles-Boyd-MD_412x296px_1663831023_original
1 MONTH AFTER 4ᵀᴴ TREATMENT
Emface_PIC_042-Before-jawline-female-Richar-Gentile-MD_412x296px_1663831267_original
Emface_PIC_042-After-jawline-female-Richar-Gentile-MD-1M-AL_412x296px_1663831267_original
Emface_PIC_035-Before-jawline-female-Yael-Halaas-MD_412x296px_1663831266_original
Emface_PIC_035-After-jawline-female-Yael-Halaas-MD-4TX_412x296px_1663831266_original
3 MONTHS AFTER 4ᵀᴴ TREATMENT
3 MONTHS AFTER 4ᵀᴴ TREATMENT

Results and client experience may vary.

Why Clinics Are Offering EMFACE

  • 20-minute hands-free treatment sessions
  • Completely non-invasive technology
  • No needles, no toxins, no downtime
  • Simultaneous muscle and skin targeting
  • Results build over time with high patient satisfaction
  • Works across multiple facial zones including: forehead, cheeks, jawline, periorbital area, and submentum

EMFACE is ideal for aesthetic clinics looking to offer next-generation facial rejuvenation treatments that support both volume and lift, without the need for injectables.

Built for Providers. Designed for Growth.

EMFACE is part of the BTL portfolio, trusted by leading clinics around the world for over 30 years.

BTL supports practices with technologies that are:

  • Easy to integrate and operator-friendly
  • Backed by clinical studies and ARTG approval
  • Supported with ongoing training, marketing, and service

Explore the BTL Technology Portfolio

Alongside EMFACE, BTL offers a suite of non-invasive systems to help clinics diversify their service offering:

EXOMIND

rTMS brain stimulation for mental wellness

EMSCULPT NEO®

Muscle building and fat reduction

EXION™

Radiofrequency and ultrasound for skin regeneration and fat reduction

EMSELLA®

Pelvic floor therapy for incontinence and sexual health

Each technology is engineered for measurable results, efficient workflows, and commercial success.

Why Partner with BTL?

  • Offices and showrooms across Australia and New Zealand
  • Proven performance in over 85 countries
  • Full support across clinical, technical, and commercial functions
  • Ongoing R&D delivering innovation for future-ready practices
  • Local training and marketing resources for long-term success

Our team works closely with clinics to ensure seamless implementation and business results.

This product is not available for purchase by the general public.
The findings showed consistent outcomes across the clinical studies.
Patient results and experience may vary.

Review Clinical Studies

Become a BTL Partner today.

Elevate your practice offering with award-winning devices.

BTL partners with clinics committed to clinical excellence and innovation.

Evidence based technologies with global clinical adoption

Comprehensive training and marketing support

Dedicated technical service and ongoing partnership

Devices registered and compliant in Australia and New Zealand

Fill in your details and our team will be in touch to discuss your goals and product suitability.

Request BTL Product Information

Country(Required)
Interested in(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

By filling the form I am aware that BTL contacts me to keep me informed about news of BTL Group and about its products and services.

Contact BTL Australia

Address:
Administration & Service:
Unit 5 / 10 Enterprise Close
West Gosford NSW 2250

Showroom:
Suite 2.05, Level 2, Building D, Talavera Corporate Center,
12-24 RTalavera Road, Macquarie Park NSW 2113

Email: info@btlmed.com.au
Phone: 0422 608 123

Contact BTL New Zealand

Address:
130 St Georges Bay Rd, Parnell,
Auckland 1052

Email: ehab@btlmed.nz / info@btlmed.nz
Ehab Jirgis , Business Development Manager +64 21 284 2628

Clinical references:

1) Gentile R, Halaas Y. Facial Plast Surg Aesthet Med. 2024;26(1):1-6. doi:10.1089/fpsam.2023.0015,

(2) Frank K, Kaye KO, Casabona G, et al. Aesthet Surg J. 2025;45(5):525-30. doi:10.1093/asj/sjaf009,

(3) Palm, M.; Kilmer, S.M. & Gentile,R. (2025): Novel HIFESTM and Synchronized Radiofrequency Effect on Periorbital Area; presented at 44th ASLMS Annual Conference on Energy-Based Medicine & Science, Orlando, 25 April 2025,

(4) Cohen JL, et al. Dermatol Surg. 2025;51(7):690-5. doi:10.1097/DSS.0000000000004613,

(5) DiBernardo B, Jacob C, Clark-Loeser L. Aesthet Surg J. 2025;45(7):709-14. doi:10.1093/asj/sjaf048.